[ RECIPIENT ENTITY RECORD ]

Novo Manufacturing

VERIFIED NODE ID: 002093 · novo-manufacturing
R TARGET NODE — CAPITAL RECIPIENT
Novo Manufacturing
SPV Denmark
Recipient Type
SPV
Primary Jurisdiction
Denmark
Registration Status
ACTIVE
Entity Intelligence [ R ]
Legal Name Novo Manufacturing
Entity Type SPV
Jurisdiction Denmark
Recipient Intelligence Summary

Novo Manufacturing represents the world-leading pharmaceutical production facilities dedicated to producing life-saving metabolic treatments. Based in Denmark, the project focuses on expanding the global supply chain for obesity drugs. It was a primary destination for institutional healthcare capital through large-scale acquisitions.

Capital Influx Log (Transactions)
Date Type Amount
23 May 2026 EQUITY $16.5B